D&D Pharmatech Inc.
Clinical-stage biopharma developing GLP-1 therapies for metabolic and neurodegenerative diseases.
347850 | KO
Overview
Corporate Details
- ISIN(s):
- KR7347850000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 수정구 금토로80번길 27 (금토동, 텔레칩스) 4층, 성남시
- Website:
- http://www.ddpharmatech.com/
- Sector:
- Manufacturing
Description
D&D Pharmatech is a clinical-stage biopharmaceutical company specializing in the development of therapies based on GLP-1 (Glucagon-like peptide-1) and related peptides. The company's pipeline primarily targets metabolic diseases, including obesity and MASH (Metabolic dysfunction-associated steatohepatitis), as well as neurodegenerative disorders. A core competency is its proprietary oral peptide delivery technology. Key candidates in its portfolio include DD01, an injectable dual GLP-1/glucagon receptor agonist for MASH that has received FDA Fast Track Designation, and an oral GLP-1 therapy for obesity. The company operates a global model, funding drug development through specialized subsidiaries, with research functions in Korea and clinical development managed by its US-based team.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-16 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 4.3 MB | ||
| 2024-04-16 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 4.2 MB | ||
| 2024-04-05 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 4.6 MB | ||
| 2024-03-29 00:00 |
감사보고서 (2023.12)
|
Korean | 407.4 KB | ||
| 2024-03-29 00:00 |
연결감사보고서 (2023.12)
|
Korean | 469.1 KB | ||
| 2024-03-25 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 7.6 MB | ||
| 2024-01-17 00:00 |
증권신고서(지분증권)
|
Korean | 3.4 MB | ||
| 2023-03-31 00:00 |
감사보고서 (2022.12)
|
Korean | 407.9 KB | ||
| 2023-03-31 00:00 |
연결감사보고서 (2022.12)
|
Korean | 459.3 KB | ||
| 2022-03-31 00:00 |
감사보고서 (2021.12)
|
Korean | 402.0 KB | ||
| 2022-03-31 00:00 |
연결감사보고서 (2021.12)
|
Korean | 464.1 KB | ||
| 2021-03-31 00:00 |
감사보고서 (2020.12)
|
Korean | 415.0 KB | ||
| 2021-03-31 00:00 |
연결감사보고서 (2020.12)
|
Korean | 461.9 KB | ||
| 2020-04-07 00:00 |
감사보고서 (2019.12)
|
Korean | 371.9 KB | ||
| 2020-04-07 00:00 |
연결감사보고서 (2019.12)
|
Korean | 415.7 KB |
Automate Your Workflow. Get a real-time feed of all D&D Pharmatech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for D&D Pharmatech Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for D&D Pharmatech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
